Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:59 pm Purchase | 2022-12-31 | 13G | CODEXIS INC CDXS | Nantahala Capital Management LLC | 4,487,782 6.800% | 1,030,581 (+29.81%) | Filing History |
| 2023-02-14 4:58 pm Sale | 2022-12-31 | 13G | CIDARA THERAPEUTICS INC CDTX | Nantahala Capital Management LLC | 218,373 6.100% | -45,150 (-17.13%) | Filing History |
| 2023-02-14 4:58 pm Sale | 2022-12-31 | 13G | AVALO THERAPEUTICS INC AVTX | Nantahala Capital Management LLC | 2,728 7.000% | -228 (-7.71%) | Filing History |
| 2023-02-14 4:56 pm Sale | 2022-12-31 | 13G | APTOSE BIOSCIENCES INC NO APTOF | Nantahala Capital Management LLC | 6,052,867 6.600% | -1,551,826 (-20.41%) | Filing History |
| 2023-02-14 4:56 pm Purchase | 2022-12-31 | 13G | ACER THERAPEUTICS INC. ACER | Nantahala Capital Management LLC | 1,226,191 7.500% | 324,901 (+36.05%) | Filing History |
| 2023-02-14 4:55 pm Purchase | 2022-12-31 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Nantahala Capital Management LLC | 184,452 7.500% | 71,910 (+63.90%) | Filing History |
| 2023-02-14 4:54 pm Sale | 2022-12-31 | 13G | UNIQURE N V QURE | Nantahala Capital Management LLC | 3,887,939 8.300% | -581,274 (-13.01%) | Filing History |
| 2023-02-14 4:54 pm Sale | 2022-12-31 | 13G | IMAX CORPORATION IMAX | Nantahala Capital Management LLC | 4,988,189 8.900% | -209,301 (-4.03%) | Filing History |
| 2023-02-14 4:52 pm Sale | 2022-12-31 | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Nantahala Capital Management LLC | 120,742 8.000% | -3,934 (-3.16%) | Filing History |
| 2023-02-14 4:51 pm Purchase | 2022-12-31 | 13G | LUXFER HOLDINGS PLC SHS LXFR | Nantahala Capital Management LLC | 2,452,319 9.000% | 334,086 (+15.77%) | Filing History |
| 2023-02-14 4:51 pm Purchase | 2022-12-31 | 13G | RED VIOLET INC RDVT | Nantahala Capital Management LLC | 1,275,088 9.200% | 251,629 (+24.59%) | Filing History |
| 2023-02-14 4:50 pm Sale | 2022-12-31 | 13G | TRAVELCENTERS AMER INC TA | Nantahala Capital Management LLC | 1,031,394 6.900% | -241,176 (-18.95%) | Filing History |
| 2023-02-14 4:49 pm Purchase | 2022-12-31 | 13G | BIOVENTUS INC BVS | Nantahala Capital Management LLC | 3,168,574 5.100% | 3,168,574 (New Position) | Filing |
| 2023-02-14 4:48 pm Purchase | 2022-12-31 | 13G | DRIVE SHACK INC DSHK | Nantahala Capital Management LLC | 65,000 7.000% | 65,000 (New Position) | Filing History |
| 2023-02-14 4:48 pm Purchase | 2022-12-31 | 13G | LYRA THERAPEUTICS INC LYRA | Nantahala Capital Management LLC | 44,417 7.000% | 44,417 (New Position) | Filing History |
| 2023-02-14 4:47 pm Sale | 2022-12-31 | 13G | FINTECH ACQUISITION CORP V CL FTCV | Nantahala Capital Management LLC | 0 0.000% | -1,324,763 (Position Closed) | Filing History |
| 2023-02-14 4:47 pm Sale | 2022-12-31 | 13G | AKUMIN INC AKU | Nantahala Capital Management LLC | 2,206,960 2.500% | -4,113,780 (-65.08%) | Filing History |
| 2023-02-14 4:46 pm Sale | 2022-12-31 | 13G | SYNDAX PHARMACEUTICALS INC SNDX | Nantahala Capital Management LLC | 975,705 1.400% | -2,074,854 (-68.02%) | Filing History |
| 2023-02-14 4:46 pm Sale | 2022-12-31 | 13G | DXP ENTERPRISES INC- DXPE | Nantahala Capital Management LLC | 338,090 1.800% | -885,168 (-72.36%) | Filing History |
| 2023-02-14 4:46 pm Sale | 2022-12-31 | 13G | CATALYST BIOSCIENCES INC N CBIO | Nantahala Capital Management LLC | 4,381 1.400% | -23,236 (-84.14%) | Filing History |